Literature DB >> 15826264

Cardiac resynchronization induces favorable neurohumoral changes.

Ayten Erol-Yilmaz1, Hein J Verberne, Tim A Schrama, Jana Hrudova, Robbert J De Winter, Berthe L F Van Eck-Smit, Rianne De Bruin, Jeroen J Bax, Martin J Schalij, Arthur A Wilde, Raymond Tukkie.   

Abstract

AIM: The aim of this article is to examine whether cardiac resynchronization therapy (CRT) induces improvements in the neurohumoral system. METHODS AND
RESULTS: Thirteen patients with HF (left ventricular (LV) ejection fraction <35%) were included. Before and after 6 months of CRT, myocardial (123)I-metaiodobenzylguanidine ((123)I-MIBG) uptake indices, used as an index of neural norepinephrine reuptake and retention, and brain natriuretic peptide (BNP) levels, used as an index of LV end-diastolic pressure, NYHA classification and echocardiographic indices were assessed. Six months of CRT resulted in significant improvement in (1) NYHA classification and reduction in QRS width (P < 0.001), (2) decrease of LV end-diastolic diameter (P = 0.005), LV end-systolic diameter (P = 0.005), septal to lateral delay (P = 0.01) and mitral regurgitation (MR, P = 0.04), (3) delayed (123)I-MIBG heart/mediastinum ratios improved (P = 0.03) and (123)I-MIBG washout decreased (P = 0.001), and (4) BNP levels decreased (P = 0.001).
CONCLUSIONS: Parallel to significant functional improvement and echocardiographic reverse remodeling and resynchronization, our data indicate that CRT induces favorable changes in the neurohumoral system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15826264     DOI: 10.1111/j.1540-8159.2005.09508.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  18 in total

1.  Effect of cardiac resynchronization therapy on libido and erectile dysfunction.

Authors:  Ahmet Vural; Aysen Agacdiken; Umut Celikyurt; Melih Culha; Goksel Kahraman; Guliz Kozdag; Dilek Ural
Journal:  Clin Cardiol       Date:  2011-06-02       Impact factor: 2.882

2.  Rethinking Resynch: Exploring Mechanisms of Cardiac Resynchroniztion Beyond Wall Motion Control.

Authors:  Khalid Chakir; David A Kass
Journal:  Drug Discov Today Dis Mech       Date:  2010

Review 3.  Role of cardiac MRI and nuclear imaging in cardiac resynchronization therapy.

Authors:  Niti R Aggarwal; Matthew W Martinez; Bernard J Gersh; Panithaya Chareonthaitawee
Journal:  Nat Rev Cardiol       Date:  2009-11-03       Impact factor: 32.419

4.  Potential pro-arrhythmic effect of cardiac resynchronization therapy.

Authors:  Osama Tayeh; Waleed Farouk; Abdo Elazab; Hassan Khald; Antonio Curnis
Journal:  J Saudi Heart Assoc       Date:  2013-05-30

5.  Role of cardiac resynchronization in end-stage heart failure patients requiring inotrope therapy.

Authors:  Sanjoy Bhattacharya; Kaleab Abebe; Marc Simon; Samir Saba; Evan Adelstein
Journal:  J Card Fail       Date:  2010-12       Impact factor: 5.712

Review 6.  Cardiac sympathetic innervation and cardiac resynchronization therapy.

Authors:  A M Scholtens; A J A T Braat; A Tuinenburg; M Meine; H J Verberne
Journal:  Heart Fail Rev       Date:  2014-09       Impact factor: 4.214

7.  Cardiac resynchronization therapy and atrial overdrive pacing for the treatment of central sleep apnoea.

Authors:  Lars Lüthje; Bernd Renner; Roger Kessels; Dirk Vollmann; Tobias Raupach; Bart Gerritse; Selcuk Tasci; Jörg O Schwab; Markus Zabel; Dieter Zenker; Peter Schott; Gerd Hasenfuss; Christina Unterberg-Buchwald; Stefan Andreas
Journal:  Eur J Heart Fail       Date:  2009-01-12       Impact factor: 15.534

8.  Cardiac sympathetic activity pre and post resynchronization therapy evaluated by 123I-MIBG myocardial scintigraphy.

Authors:  Silvana A D'Orio Nishioka; Martino Martinelli Filho; Simone C Soares Brandão; Maria Clementina Giorgi; Marcelo L C Vieira; Roberto Costa; Wilson Mathias; José Cláudio Meneghetti
Journal:  J Nucl Cardiol       Date:  2007-10-18       Impact factor: 5.952

9.  Prognostic value of sympathetic innervation and cardiac asynchrony in dilated cardiomyopathy.

Authors:  Alain Manrique; Mathieu Bernard; Anne Hitzel; Fabrice Bauer; Jean-François Ménard; Rémi Sabatier; Arnold Jacobson; Pierre Véra; Denis Agostini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-06       Impact factor: 9.236

10.  SmartDelay determined AV optimization: a comparison of AV delay methods used in cardiac resynchronization therapy (SMART-AV): rationale and design.

Authors:  Kenneth M Stein; Kenneth A Ellenbogen; Michael R Gold; Bernd Lemke; Ignacio Fernández Lozano; Suneet Mittal; Francis G Spinale; Jennifer E Van Eyk; Alan D Waggoner; Timothy E Meyer
Journal:  Pacing Clin Electrophysiol       Date:  2009-10-10       Impact factor: 1.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.